Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

ARRY: New 8K irt Genentech agreement. Expansion to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ThomasS Member Profile
 
Followed By 12
Posts 2,362
Boards Moderated 0
Alias Born 05/05/05
160x600 placeholder
S&P 500, Dow Close At Record Levels
The U.S. stock market rallied on Friday, sending the S&P 500 and Dow Jones Industrial Average into record territory, after a surprise stimulus plan from the Bank of Japan was announced.
Top Equities Stories Of The Day
Omega Healthcare to Buy Aviv REIT
Sony Posts Hefty Loss
Starbucks Sales Growth Disappoints; Delivery Is Coming -- 3rdUpdate
Two Picks to Dig Into Pipelines, Shale Energy -- Barron's
U.S. Stocks, Bonds Dip on Fed Outlook
Twitter Demotes Product Chief Daniel Graf
Byron Wien: Slow Growth Good for Stock Market -- Barron's
Jefferies Expected to Book up to $15 Million Loss on Toms Shoes Debt, Sources Say -- Update
ThomasS   Monday, 09/08/08 07:36:58 AM
Re: None
Post # of 183413 
ARRY: New 8K irt Genentech agreement. Expansion to include a new target under the existing collaboration #msg-29627295:

Array BioPharma Inc. (the "Company") and Genentech, Inc. ("Genentech") have entered into an amendment effective as of September 1, 2008 (the "Amendment") to the Drug Discovery Collaboration Agreement between the Company and Genentech dated December 22, 2003, as amended (the "Agreement"). Under the Amendment, the Company and Genentech added a new collaboration target and agreed to increase the number of the Company's full-time equivalent scientists ("FTEs") performing services under the Agreement. Genentech continues to have the right to reduce the number of FTEs under the Agreement after January 1, 2010, subject to higher minimum levels set forth in the Amendment. The Amendment also provides for the payment of a one-time license fee, research funding and milestone payments to the Company in connection with the new target.

"Illegitimacy is something we should talk about in terms of not having it."

- Dan Quayle
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist